Fawzy A. Elbarbry

Fawzy A. Elbarbry is a Professor at Pacific University in the College of Health Professions Department of Pharmacy. He holds a PhD in Pharmacy (Drug Metabolism and Pharmacokinetics) from the University of Saskatchewan (2006), an MS in Analytical Chemistry from the University of Tanta (2002), and a BS in Pharmaceutical Sciences (1993). He is Board Certified in Pharmacotherapy (BCPS, 2018) and completed a Postdoctoral Fellowship in the Department of Medicine at the University of Saskatchewan (2006).

• PhD, Pharmacy (Drug Metabolism and Pharmacokinetics), University of Saskatchewan, Canada (2006)
• MS, Analytical Chemistry, University of Tanta, Egypt (2002)
• BCPS, American Pharmacists Association (2018)
• FPGEC, National Association of Boards of Pharmacy (2010)

His research focuses on drug metabolism, particularly the impact of herbal remedies on drug-metabolizing enzymes and arachidonic acid metabolism for hypertension treatment. Recent work identified sulforaphane from broccoli as a potential antihypertensive agent through inhibition of arachidonic acid metabolism, with implications for herb-drug interactions.

Dr. Elbarbry has received significant funding, including an NIH grant of $365,966 for a three-year project on alternative hypertension treatments. His publications span topics like pharmacokinetics in amputees, serotonin toxicity from antibiotics, and natural product translation to clinical practice.

• NIH Grant ($365,966, 2021) – Alternative Treatments for Hypertension
• Board Certified Pharmacotherapy Specialist (BCPS) – American Pharmacists Association (2018)

His work integrates pharmacokinetics, natural product research, and clinical pharmacology to address challenges in drug interactions and cardiovascular disease management.